{
    "address1": "60 Binney Street",
    "city": "Cambridge",
    "state": "MA",
    "zip": "02142",
    "country": "United States",
    "phone": "339 499 9300",
    "website": "https://www.2seventybio.com",
    "industry": "Biotechnology",
    "industryDisp": "Biotechnology",
    "sector": "Healthcare",
    "sectorDisp": "Healthcare",
    "longBusinessSummary": "2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. The company's products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and chimeric antigen receptor-T cell product candidates for the treatment of multiple myeloma. It has a collaboration arrangement with Bristol-Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.",
    "fullTimeEmployees": 425,
    "companyOfficers": [
        {
            "maxAge": 1,
            "name": "Mr. Nick  Leschly",
            "age": 49,
            "title": "Pres, CEO & Director",
            "yearBorn": 1973,
            "fiscalYear": 2022,
            "totalPay": 1811892,
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Dr. Philip D. Gregory D. Phil., DPHIL",
            "age": 51,
            "title": "Chief Scientific Officer",
            "yearBorn": 1971,
            "fiscalYear": 2022,
            "totalPay": 1013261,
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Mr. William D. Baird III, M.B.A.",
            "age": 50,
            "title": "Chief Financial Officer",
            "yearBorn": 1972,
            "fiscalYear": 2021,
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Ms. Susan  Abu-Absi Ph.D.",
            "title": "Chief Technology & Manufacturing Officer",
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Ms. Teresa L. Jurgensen J.D.",
            "title": "Sr. VP, Gen. Counsel & Corp. Sec.",
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Ms. Kathleen A. Wilkinson",
            "age": 50,
            "title": "Chief People Officer",
            "yearBorn": 1972,
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Ms. Jenn  Snyder",
            "title": "Sr. VP of Corp. Affairs",
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Dr. Steven  Bernstein M.D.",
            "title": "Chief Medical Officer",
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Dr. Melissa  Price Ph.D.",
            "age": 48,
            "title": "Sr. VP of Devel. Operations & Portfolio Strategy",
            "yearBorn": 1974,
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Michael  Certo",
            "title": "VP & Head of Genome Editing",
            "exercisedValue": 0,
            "unexercisedValue": 0
        }
    ],
    "auditRisk": 7,
    "boardRisk": 6,
    "compensationRisk": 9,
    "shareHolderRightsRisk": 8,
    "overallRisk": 8,
    "governanceEpochDate": 1690848000,
    "compensationAsOfEpochDate": 1672444800,
    "maxAge": 86400,
    "priceHint": 2,
    "previousClose": 5.47,
    "open": 5.47,
    "dayLow": 5.26,
    "dayHigh": 5.54,
    "regularMarketPreviousClose": 5.47,
    "regularMarketOpen": 5.47,
    "regularMarketDayLow": 5.26,
    "regularMarketDayHigh": 5.54,
    "payoutRatio": 0.0,
    "forwardPE": -2.4122808,
    "volume": 829812,
    "regularMarketVolume": 829812,
    "averageVolume": 983858,
    "averageVolume10days": 1311750,
    "averageDailyVolume10Day": 1311750,
    "bid": 5.25,
    "ask": 5.54,
    "bidSize": 1800,
    "askSize": 1300,
    "marketCap": 277555296,
    "fiftyTwoWeekLow": 5.26,
    "fiftyTwoWeekHigh": 17.56,
    "priceToSalesTrailing12Months": 1.8848745,
    "fiftyDayAverage": 8.4777,
    "twoHundredDayAverage": 10.891475,
    "trailingAnnualDividendRate": 0.0,
    "trailingAnnualDividendYield": 0.0,
    "currency": "USD",
    "enterpriseValue": 258296176,
    "profitMargins": -1.22327,
    "floatShares": 46196789,
    "sharesOutstanding": 50464600,
    "sharesShort": 7077166,
    "sharesShortPriorMonth": 8947239,
    "sharesShortPreviousMonthDate": 1689292800,
    "dateShortInterest": 1692057600,
    "sharesPercentSharesOut": 0.1402,
    "heldPercentInsiders": 0.01656,
    "heldPercentInstitutions": 1.01716,
    "shortRatio": 5.21,
    "shortPercentOfFloat": 0.1419,
    "impliedSharesOutstanding": 50464600,
    "bookValue": 7.315,
    "priceToBook": 0.7518797,
    "lastFiscalYearEnd": 1672444800,
    "nextFiscalYearEnd": 1703980800,
    "mostRecentQuarter": 1688083200,
    "netIncomeToCommon": -180132000,
    "trailingEps": -4.04,
    "forwardEps": -2.28,
    "enterpriseToRevenue": 1.754,
    "enterpriseToEbitda": -1.39,
    "52WeekChange": -0.6330887,
    "SandP52WeekChange": 0.09306288,
    "exchange": "NMS",
    "quoteType": "EQUITY",
    "symbol": "TSVT",
    "underlyingSymbol": "TSVT",
    "shortName": "2seventy bio, Inc.",
    "longName": "2seventy bio, Inc.",
    "firstTradeDateEpochUtc": 1635946200,
    "timeZoneFullName": "America/New_York",
    "timeZoneShortName": "EDT",
    "uuid": "f4b7e673-d101-3831-ada5-26d60bd8a06b",
    "messageBoardId": "finmb_700837637",
    "gmtOffSetMilliseconds": -14400000,
    "currentPrice": 5.5,
    "targetHighPrice": 33.0,
    "targetLowPrice": 13.0,
    "targetMeanPrice": 24.33,
    "targetMedianPrice": 25.0,
    "recommendationMean": 1.6,
    "recommendationKey": "buy",
    "numberOfAnalystOpinions": 6,
    "totalCash": 282836992,
    "totalCashPerShare": 5.605,
    "ebitda": -185862000,
    "totalDebt": 263578000,
    "quickRatio": 4.887,
    "currentRatio": 4.988,
    "totalRevenue": 147254000,
    "debtToEquity": 71.723,
    "revenuePerShare": 3.428,
    "returnOnAssets": -0.1633,
    "returnOnEquity": -0.48262,
    "grossProfits": -183458000,
    "freeCashflow": -158457632,
    "operatingCashflow": -198951008,
    "revenueGrowth": 1.674,
    "grossMargins": -0.7914,
    "ebitdaMargins": -1.26219,
    "operatingMargins": -1.32463,
    "financialCurrency": "USD",
    "trailingPegRatio": null,
    "parent_etfs": [
        "GNOM"
    ]
}